Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-15, Stock:LLY, The news for the past five days is as follows:
2019-02-08: NEWS1: Teva (TEVA) to Report Q4 Earnings: What's in the Cards?.NEWS2: Mattel soars while Hasbro and Goodyear tumble.NEWS3: Incyte Down as FDA Extends Review Period of Jakafi for GVHD.NEWS4: 7 Fundamentally Sound Dividend Stocks to Buy.NEWS5: Eli Lilly and Company -- Moody's: Lilly's animal health divestiture will reduce scale and diversity.NEWS6: Lilly to Participate in Guggenheim Healthcare Talks Idea Forum.NEWS7: Eli Lilly to Unload Its Remaining Stock in Elanco Animal Health.NEWS8: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS9: Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs.NEWS10: Stocks making the biggest moves premarket: Hasbro, Coty, Expedia, Verizon & more.NEWS11: New Research Coverage Highlights Eli Lilly, Newell Brands, Novanta, Carrols Restaurant Group, 8x8, and Quanta Services — Consolidated Revenues, Company Growth, and Expectations for 2019.NEWS12: Eli Lilly to divest remaining stake in Elanco via an exchange offer.NEWS13: Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health.
2019-02-11: NEWS1: Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake.NEWS2: Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake.NEWS3: Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake.NEWS4: Incyte Down as FDA Extends Review Period of Jakafi for GVHD.NEWS5: Incyte Down as FDA Extends Review Period of Jakafi for GVHD.NEWS6: Teva (TEVA) to Report Q4 Earnings: What's in the Cards?.NEWS7: Teva (TEVA) to Report Q4 Earnings: What's in the Cards?.
2019-02-12: NEWS1: Top Stock Reports for Disney, Eli Lilly & U.S. Bancorp.NEWS2: Top Stock Reports for Disney, Eli Lilly & U.S. Bancorp.NEWS3: Pfizer or Eli Lilly: Who Is Expected to Report Higher EPS Growth?.NEWS4: Notable Tuesday Option Activity: CAI, LLY, VRNS.NEWS5: Notable Tuesday Option Activity: CAI, LLY, VRNS.NEWS6: Top Stock Reports for Disney, Eli Lilly & U.S. Bancorp.NEWS7: Pfizer or Eli Lilly: Who Will Report Better Revenue Growth?.NEWS8: What Analysts Recommend for Pfizer and Eli Lilly in February.
2019-02-13: NEWS1: Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report.NEWS2: Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report.NEWS3: Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report.NEWS4: Moat Index: Dramatic Sector Allocation Shift in 2018.NEWS5: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS6: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS7: The Zacks Analyst Blog Highlights: Disney, Eli Lilly, U.S. Bancorp, Prudential and Alexion.NEWS8: The Zacks Analyst Blog Highlights: Disney, Eli Lilly, U.S. Bancorp, Prudential and Alexion.NEWS9: 5 Tiny Biotech Stocks With Superb Growth Potential.NEWS10: 5 Tiny Biotech Stocks With Superb Growth Potential.NEWS11: What Are the Key Growth Drivers for Eli Lilly in Fiscal 2019?.NEWS12: J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod.NEWS13: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019.NEWS14: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019.NEWS15: The Zacks Analyst Blog Highlights: Disney, Eli Lilly, U.S. Bancorp, Prudential and Alexion.NEWS16: Pfizer and Eli Lilly: How Dividends and Tax Rates Stack Up.NEWS17: 5 Tiny Biotech Stocks With Superb Growth Potential.NEWS18: Pfizer or Eli Lilly: Who Is Controlling Expenses Better?.NEWS19: Earnings Reaction History: Eli Lilly & Co., 50.0% Follow-Through Indicator, 2.4% Sensitive.NEWS20: Earnings Reaction History: Eli Lilly & Co., 50.0% Follow-Through Indicator, 2.4% Sensitive.
2019-02-14: NEWS1: Lilly To Participate in Leerink Partners Global Healthcare Conference.NEWS2: Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat.NEWS3: Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat.NEWS4: 5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings.NEWS5: 5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings.NEWS6: Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat.NEWS7: Thursday’s Vital Data: Eli Lilly, Twitter and Freeport-McMoRan.NEWS8: Thursday’s Vital Data: Eli Lilly, Twitter and Freeport-McMoRan.NEWS9: 5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings.NEWS10: Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down.NEWS11: Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down.NEWS12: Thursday’s Vital Data: Eli Lilly, Twitter and Freeport-McMoRan.NEWS13: Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down.NEWS14: Boehringer Ingelheim and Lilly announce the CAROLINA® cardiovascular outcome trial of Tradjenta® met its primary endpoint of non-inferiority compared with glimepiride.

Answer: Rise